Panagora Asset Management’s Antares Pharma, Inc. ATRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-916,896
| Closed | -$3.76M | – | 1646 |
|
|
2022
Q1 | $3.76M | Buy |
916,896
+74,286
| +9% | +$269K | 0.02% | 483 |
|
|
2021
Q4 | $3.01M | Sell |
842,610
-8,462
| -1% | -$29.6K | 0.02% | 527 |
|
|
2021
Q3 | $3.1M | Sell |
851,072
-14,880
| -2% | -$60.2K | 0.02% | 551 |
|
|
2021
Q2 | $3.78M | Buy |
865,952
+67,077
| +8% | +$273K | 0.02% | 510 |
|
|
2021
Q1 | $3.28M | Buy |
798,875
+13,794
| +2% | +$59.8K | 0.02% | 580 |
|
|
2020
Q4 | $3.13M | Buy |
785,081
+5,306
| +0.7% | +$17.2K | 0.02% | 555 |
|
|
2020
Q3 | $2.1M | Buy |
779,775
+553,942
| +245% | +$1.53M | 0.01% | 620 |
|
|
2020
Q2 | $621K | Buy |
225,833
+79,245
| +54% | +$221K | ﹤0.01% | 1122 |
|
|
2020
Q1 | $346K | Buy |
146,588
+123,748
| +542% | +$421K | ﹤0.01% | 1275 |
|
|
2019
Q4 | $107K | Buy |
+22,840
| New | +$93.5K | ﹤0.01% | 1787 |
|
|
2019
Q1 | – | Sell |
-460
| Closed | -$1K | – | 2600 |
|
|
2018
Q4 | $1K | Hold |
460
| – | – | ﹤0.01% | 2434 |
|
|
2018
Q3 | $2K | Sell |
460
-1,297,407
| -100% | -$4.01M | ﹤0.01% | 2373 |
|
|
2018
Q2 | $3.35M | Buy |
1,297,867
+2,576
| +0.2% | +$6.41K | 0.01% | 681 |
|
|
2018
Q1 | $2.85M | Buy |
1,295,291
+389,274
| +43% | +$876K | 0.01% | 743 |
|
|
2017
Q4 | $1.8M | Buy |
906,017
+502,552
| +125% | +$1.09M | 0.01% | 923 |
|
|
2017
Q3 | $1.31M | Buy |
+403,465
| New | +$1.24M | 0.01% | 1025 |
|
|
2016
Q2 | – | Sell |
-1,645,501
| Closed | -$1.43M | – | 2367 |
|
|
2016
Q1 | $1.43M | Buy |
1,645,501
+425,756
| +35% | +$412K | 0.01% | 974 |
|
|
2015
Q4 | $1.48M | Buy |
1,219,745
+341,917
| +39% | +$476K | 0.01% | 918 |
|
|
2015
Q3 | $1.49M | Buy |
877,828
+209,267
| +31% | +$410K | 0.01% | 863 |
|
|
2015
Q2 | $1.39M | Buy |
668,561
+186,890
| +39% | +$453K | 0.01% | 953 |
|
|
2015
Q1 | $1.3M | Buy |
+481,671
| New | +$1.22M | 0.01% | 964 |
|
Other funds holding ATRS
Panagora Asset Management's ATRS Position: Q2 2022 in Review
Panagora Asset Management sold out of Antares Pharma, Inc. (ATRS) in Q2 2022, closing a stake of 916,896 shares — an estimated $3.76M sold.
Panagora Asset Management first reported a position in ATRS in Q1 2015 and held it in 21 quarters. The position peaked at $3.78M in Q2 2021. 1 fund tracked by Wall St. Rank holds ATRS as of Q2 2022.
- Panagora Asset Management reported no remaining Antares Pharma, Inc. position as of Q2 2022 after selling out during the quarter.
- Panagora Asset Management sold 916,896 Antares Pharma, Inc. shares in Q2 2022, an estimated $3.76M.
- Panagora Asset Management first reported a position in Antares Pharma, Inc. in Q1 2015 and held it in 21 quarters.
- Panagora Asset Management's Antares Pharma, Inc. position peaked at $3.78M in Q2 2021.
- 1 fund tracked by Wall St. Rank held Antares Pharma, Inc. as of Q2 2022.
Based on Panagora Asset Management's 13F filing for Q2 2022, filed 15 Aug 2022.